AGK and diffuse large B-cell lymphoma: We found that AS1842856 inhibited BCL-2 expression at both mRNA and protein levels in a dose-dependent manner and reversed the sensitivity of DLBCL to venetoclax in shRNA AGK SU-DHL4 cells (Figure 5A-C).